Inovio Pharmaceuticals Inc.

10/10/2025 | Press release | Distributed by Public on 10/10/2025 11:20

European Society of Gene and Cell Therapy Congress Employment of the CELLECTRA® in vivo gene delivery platform in a first in human (FIH) DNA encoded monoclonal antibody (DMAb)[...]

Inovio Pharmaceuticals Inc. published this content on October 10, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 10, 2025 at 17:21 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]